Long-Term Outcomes of Stereotactic Radiosurgery for Pineocytomas: An International Multicenter Study

医学 放射外科 期限(时间) 医学物理学 多中心研究 梅德林 放射科 外科 放射治疗 随机对照试验 天文 物理 政治学 法学
作者
Andréanne Hamel,Jean-Nicolas Tourigny,Ajay Niranjan,L. Dade Lunsford,Zhishuo Wei,Priyanka Srinivasan,Roman Liščák,Jaromír May,Nuria Martínez Moreno,Roberto Martínez Álvarez,Cheng‐Chia Lee,Huai‐Che Yang,Manjul Tripathi,Narendra Kumar,Elad Mashiach,Douglas Kondziolka,Robert G. Briggs,Cheng Yu,Gabriel Zada,Andrea Franzini,Guido Pecchioli,Gregory Bowden,Sam Dayawansa,Jason P. Sheehan,David Mathieu
出处
期刊:Neurosurgery [Lippincott Williams & Wilkins]
标识
DOI:10.1227/neu.0000000000003261
摘要

BACKGROUND AND OBJECTIVES: Pineocytomas are grade 1 tumors arising from the pineal parenchyma. Gross total resection can potentially cure these benign lesions but can be associated with morbidity. This study was designed to provide multi-institutional data to evaluate the results of stereotactic radiosurgery (SRS) for pineocytomas. METHODS: Centers participating in the International Radiosurgery Research Foundation were asked to review their database and provide data for patients who had SRS for histology confirmed grade 1 pineocytomas, for whom clinical and imaging follow-up of at least 6 months was available. RESULTS: In total, 38 patients underwent SRS as part of the management of a pineocytoma. The median age at SRS was 39 years (range 8-76). SRS was performed as primary approach in 68%, adjuvant after partial resection 19%, and at recurrence in 13% of patients. The median margin dose was 15 Gy (range 11-25 Gy). The median treatment volume was 3.35 cc (range 0.1-17.9 cc). Local tumor control was achieved in 92% of patients, with a mean actuarial progression-free survival of 21.6 years (median not reached). At last follow-up, 82% were still controlled, 8% had local recurrence, and 10% had cerebrospinal fluid dissemination. Tumor control was significantly better when SRS was used as primary care compared with the adjuvant or recurrent setting ( P = .016). Five patients (13%) died during follow-up, all from tumor progression. The actuarial mean survival duration was 24.3 years, with a 5-year survival rate of 91%, and an estimated rate of 76% at 29 years. Larger tumor volume at SRS was found to be correlated to increased risk of death ( P = .045). Transient symptomatic adverse radiation effects were observed in 4 patients (11%). CONCLUSION: SRS appears safe and effective for the management of pineocytomas. Long-term tumor control is achieved in most cases. SRS can be offered to selected patients as an alternative to surgical resection.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
莫燕梦发布了新的文献求助10
刚刚
香蕉觅云应助Super_跃采纳,获得10
刚刚
刚刚
Vito完成签到 ,获得积分10
1秒前
见青完成签到,获得积分10
1秒前
1秒前
京墨发布了新的文献求助10
2秒前
在水一方应助wocala采纳,获得10
2秒前
2秒前
caixiayin发布了新的文献求助10
3秒前
3秒前
飞快的奇异果完成签到,获得积分10
4秒前
4秒前
4秒前
顾矜应助maiyatang采纳,获得10
4秒前
LLL发布了新的文献求助10
4秒前
4秒前
6秒前
6秒前
易安发布了新的文献求助30
6秒前
ELend完成签到,获得积分10
7秒前
7秒前
Sun发布了新的文献求助10
7秒前
laowang完成签到,获得积分10
7秒前
fujun完成签到,获得积分10
8秒前
8秒前
zyx发布了新的文献求助10
8秒前
夜半发布了新的文献求助10
8秒前
8秒前
NexusExplorer应助DJ采纳,获得10
8秒前
莫燕梦完成签到,获得积分10
9秒前
10秒前
10秒前
YY完成签到 ,获得积分10
11秒前
Hepatology发布了新的文献求助10
11秒前
绿色的yu完成签到 ,获得积分10
11秒前
11秒前
fgjkl完成签到 ,获得积分10
12秒前
12秒前
13秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Handbook of Marine Craft Hydrodynamics and Motion Control, 2nd Edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3987223
求助须知:如何正确求助?哪些是违规求助? 3529513
关于积分的说明 11245651
捐赠科研通 3268108
什么是DOI,文献DOI怎么找? 1804027
邀请新用户注册赠送积分活动 881303
科研通“疑难数据库(出版商)”最低求助积分说明 808650